4 months Pfizer’s earnings crush estimates as company raises guidance MarketWatch

   X     

4 months Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen. Investor's Business Daily

   X     

4 months Pfizer (NYSE:PFE) Shares Up 1.6% – Here’s Why MarketBeat

   X     

4 months Will Non-COVID Drugs Again Boost Pfizer’s Top Line in Q3 Earnings? Zacks

   X     

4 months Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? Zacks

   X     

4 months Welch Group LLC Has $46.08 Million Position in Pfizer Inc. (NYSE:PFE) MarketBeat

   X     

4 months Pfizer management looks to show turnaround as Starboard looms Investing.com

   X     

4 months These 7 Blunt Words Just Opened a Can of Worms For Pfizer’s Stock Yahoo Finance

   X     

4 months Pathway Financial Advisers LLC Has $1.15 Million Stock Position in Pfizer Inc. (NYSE:PFE) MarketBeat

   X     

4 months Pfizer’s Activist Battle Might Fizzle—but Its Stock Probably Won’t The Wall Street Journal

   X     

4 months Haleon: Too Vanilla For My Liking – I See Why GSK & Pfizer Wanted Out Seeking Alpha

   X     

4 months Final Trades: Pfizer, S&P Aerospace and Defense, and Live Nation YouTube

   X     

4 months Pfizer (NYSE:PFE) Trading Up 0.1% – Time to Buy? MarketBeat

   X     

4 months As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch Fortune

   X     

4 months Gear Up for Pfizer (PFE) Q3 Earnings: Wall Street Estimates for Key Metrics Zacks

   X     

4 months The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen Zacks

   X     

4 months Pfizer Inc. (NYSE:PFE) Shares Sold by Allspring Global Investments Holdings LLC MarketBeat

   X     

4 months Starboard Slams Pfizer for R&D Inefficiencies, Overpaid Acquisitions Zacks

   X     

4 months Pfizer (NYSE:PFE) Earns Overweight Rating from Cantor Fitzgerald MarketBeat

   X     

4 months PFE Gets FDA Nod for Expanded Use of RSV Vaccine Abrysvo Zacks

   X     

4 months The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen Zacks

   X     

4 months Sequoia Financial Advisors LLC Grows Stock Holdings in Pfizer Inc. (NYSE:PFE) MarketBeat

   X     

4 months The term premium and the bond vigilantes Financial Times

   X     

4 months Pfizer (NYSE:PFE) Trading Down 0.6% – Here’s Why MarketBeat

   X     

4 months Is Pfizer’s Attractive Valuation Enough to Invest in the Stock? Zacks

   X     

4 months Starboard Hammers Pfizer Execs For Failing To Deliver On ‘Best Pipeline’ Promises Investor's Business Daily

   X     

4 months Starboard Value CEO Jeff Smith: Pfizer needs to do a better job disciplining itself on investments YouTube

   X     

4 months Starboard Value CEO says Pfizer’s board should hold management accountable Investing.com

   X     

4 months Zacks Research Forecasts Pfizer’s FY2025 Earnings (NYSE:PFE) MarketBeat

   X     

4 months The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi Zacks

   X     

4 months Claro Advisors LLC Reduces Holdings in Pfizer Inc. (NYSE:PFE) MarketBeat

   X     

4 months Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note Zacks

   X     

4 months Nvidia Among Five Best S&P 500 Stocks Today Investor's Business Daily

   X     

4 months Pfizer (NYSE:PFE) Trading Down 0.7% – Here’s What Happened MarketBeat

   X     

4 months Penn Davis Mcfarland Inc. Takes Position in Pfizer Inc. (NYSE:PFE) MarketBeat

   X     

4 months Pfizer: Activists Clouding A Promising Picture Seeking Alpha

   X     

4 months Creative Planning Has $52.69 Million Holdings in Pfizer Inc. (NYSE:PFE) MarketBeat

   X     

4 months Pfizer Inc. (NYSE:PFE) Receives Average Rating of “Moderate Buy” from Analysts MarketBeat

   X     

4 months He Made Pfizer a Household Name. Wall Street Wants More. Yahoo Finance

   X